Association between Fathers' Use of Heated Tobacco Products and Urinary Cotinine Concentrations in Their Spouses and Children

Int J Environ Res Public Health. 2022 May 21;19(10):6275. doi: 10.3390/ijerph19106275.

Abstract

Heated tobacco products (HTPs) have become increasingly popular among smokers, especially among young adults in Japan in recent years. Assessments of secondhand tobacco smoke (SHS) exposure due to HTPs are scarce. The present study aimed to assess the urinary levels of total nicotine metabolites (TNMs) of non-smoking spouses and their children following SHS exposure due to their fathers' use of HTPs. A total of 41 families including 129 participants were recruited between 2018 and 2021. The number of non-smoking spouses and children of the fathers who smoke combustion cigarettes, the fathers who use HTPs, and the fathers who are non-users or have never smoked was 27, 66, and 36, respectively. The urinary levels of TNMs, including cotinine (Cot) and 3'-hydroxycotinine (3-OHCot), were measured using liquid chromatography/tandem mass spectrometry (LC/MS/MS). The spouses and children of fathers who use HTPs had significantly higher levels of TNMs in their urine compared to those with fathers who were non-smokers or non-users. The current study is the first to assess SHS exposure due to HTP use, and to suggest the importance of strategies to prevent exposure to SHS from HTP use in public places and educational strategies to protect non-smokers from secondhand HTP aerosol exposure in households and other private places.

Keywords: biomarker; cotinine; heated tobacco products; secondhand smoke.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Cotinine* / urine
  • Fathers
  • Humans
  • Male
  • Nicotine
  • Spouses
  • Tandem Mass Spectrometry
  • Tobacco Products*
  • Young Adult

Substances

  • Nicotine
  • Cotinine

Grants and funding

This work was supported in part by the practical research project for lifestyle-related diseases, including cardiovascular diseases and diabetes mellitus, from the Japan Agency for Medical Research and Development, AMED (18059293), and the Health and Labour Science Research Grants from the Ministry of Health, Labour, and Welfare of the Japanese Government (20FA1004).